{"protocolSection": {"identificationModule": {"nctId": "NCT00189436", "orgStudyIdInfo": {"id": "BUD ER 3425"}, "secondaryIdInfos": [{"id": "RC - 3425", "type": "OTHER", "domain": "Institutional/Allegheny Singer Research Institute"}], "organization": {"fullName": "West Penn Allegheny Health System", "class": "OTHER"}, "briefTitle": "Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children", "officialTitle": "A Pilot Study to Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Pediatric Patients Following Discharge From the Emergency Department/Outpatient Care Facility", "acronym": "BudER"}, "statusModule": {"statusVerifiedDate": "2021-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2003-03"}, "primaryCompletionDateStruct": {"date": "2009-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2009-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2005-09-12", "studyFirstSubmitQcDate": "2005-09-12", "studyFirstPostDateStruct": {"date": "2005-09-19", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-07-08", "resultsFirstSubmitQcDate": "2014-07-08", "resultsFirstPostDateStruct": {"date": "2014-08-04", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2021-01-08", "lastUpdatePostDateStruct": {"date": "2021-02-01", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR_INVESTIGATOR", "investigatorFullName": "Deborah Gentile", "investigatorTitle": "Co-Investigator", "investigatorAffiliation": "West Penn Allegheny Health System"}, "leadSponsor": {"name": "Deborah Gentile", "class": "OTHER"}, "collaborators": [{"name": "AstraZeneca", "class": "INDUSTRY"}]}, "descriptionModule": {"briefSummary": "Subjects aged 1-8 years who have been discharged from the emergency department/outpatient care facility with a diagnosis of asthma/bronchospasm/wheezing after usual standard care will be enrolled into this open-label, randomized, parallel-group study to compare the efficacy of nebulized budesonide and oral corticosteroids in preventing asthma exacerbation relapse rates during the 21-day follow-up period.", "detailedDescription": "Secondary outcomes include urinary cortisol-creatinine rations, symptom severity scores and peak flow rates."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "PREVENTION", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 61, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Treatment with Budesonide", "type": "ACTIVE_COMPARATOR", "description": "Subject is treated with nebulized budesonide 0.5 BID for 3 weeks", "interventionNames": ["Drug: Nebulized Budesonide"]}, {"label": "Usual care", "type": "ACTIVE_COMPARATOR", "description": "Subject is treated with usual care as provided by the doctor. Usual care normally consists of treatment with albuterol with or without an oral steroid.", "interventionNames": ["Drug: Usual care (albuterol with or without oral steroid)"]}], "interventions": [{"type": "DRUG", "name": "Nebulized Budesonide", "description": "Subject is treated with nebulized budesonide 0.5 BID for 3 weeks", "armGroupLabels": ["Treatment with Budesonide"]}, {"type": "DRUG", "name": "Usual care (albuterol with or without oral steroid)", "description": "Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)", "armGroupLabels": ["Usual care"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Wheezing/Asthma/Bronchospasm Relapse Rate", "description": "This was defined as the percentage of subjects in each group (treatment with budesonide versus usual care) having an unscheduled acute visit to primary care, urgent care or an emergency department during the study period.", "timeFrame": "3 weeks"}], "secondaryOutcomes": [{"measure": "Urinary Cortisol Levels", "description": "This was defined as the mean +/- standard deviation of 12 hour urinary cortisol levels in each group (treatment with budesonide versus usual care).", "timeFrame": "3 weeks"}, {"measure": "Forced Expiratory Volume in 1 Second (FEV1)", "description": "This was defined as the mean +/- standard deviation of FEV1 in each group (treatment with budesonide versus usual care.", "timeFrame": "3 weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Children ages 1-8 years old\n* Discharge from emergency department/outpatient clinic with a diagnosis of asthma exacerbation after usual standard care\n* Subjects must be able to show efficient use with a jet nebulizer\n\nExclusion Criteria:\n\n* Subjects requiring hospitalization\n* Subjects receiving oral steroids 1 week prior to presentation to emergency department.\n* Subjects with FEV1 \\< 50% of predicted\n* Subjects with co-morbid medical conditions (renal or cardiovascular disease)\n* Subjects with reported history of HIV\n* Subjects unable to follow up for study visits\n* Subjects who are frequently enuretic", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "1 Year", "maximumAge": "8 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "David Skoner, MD", "affiliation": "West Penn Allegheny Health System", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Bellevue Pediatric Associates", "city": "Bellevue", "state": "Pennsylvania", "zip": "15202", "country": "United States", "geoPoint": {"lat": 40.49396, "lon": -80.05172}}, {"facility": "Allegheny General Hospital", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15212", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Treatment With Budesonide", "description": "Subject is treated with nebulized budesonide 0.5 BID for 3 weeks\n\nNebulized Budesonide: Subject is treated with nebulized budesonide 0.5 BID for 3 weeks"}, {"id": "FG001", "title": "Usual Care", "description": "Subject is treated with usual care as provided by the doctor. Usual care normally consists of treatment with albuterol with or without an oral steroid.\n\nUsual care (albuterol with or without oral steroid): Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "31"}, {"groupId": "FG001", "numSubjects": "30"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "23"}, {"groupId": "FG001", "numSubjects": "25"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "8"}, {"groupId": "FG001", "numSubjects": "5"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "61 subjects were enrolled and 31 were randomized to nebulized budesonide and 30 to standard of care. 74% of subjects enrolled in the nebulized budesonide and 83% enrolled in the standard care group completed the study.", "groups": [{"id": "BG000", "title": "Treatment With Budesonide", "description": "Subject is treated with nebulized budesonide 0.5 BID for 3 weeks\n\nNebulized Budesonide: Subject is treated with nebulized budesonide 0.5 BID for 3 weeks"}, {"id": "BG001", "title": "Usual Care", "description": "Subject is treated with usual care as provided by the doctor. Usual care normally consists of treatment with albuterol with or without an oral steroid.\n\nUsual care (albuterol with or without oral steroid): Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "30"}, {"groupId": "BG002", "value": "61"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "4.8", "spread": "2.0"}, {"groupId": "BG001", "value": "5.4", "spread": "1.6"}, {"groupId": "BG002", "value": "5.1", "spread": "0.084"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "23"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "38"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Wheezing/Asthma/Bronchospasm Relapse Rate", "description": "This was defined as the percentage of subjects in each group (treatment with budesonide versus usual care) having an unscheduled acute visit to primary care, urgent care or an emergency department during the study period.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of cases of asthma relapse", "timeFrame": "3 weeks", "groups": [{"id": "OG000", "title": "Treatment With Budesonide", "description": "Subject is treated with nebulized budesonide 0.5 BID for 3 weeks\n\nNebulized Budesonide: Subject is treated with nebulized budesonide 0.5 BID for 3 weeks"}, {"id": "OG001", "title": "Usual Care", "description": "Subject is treated with usual care as provided by the doctor. Usual care normally consists of treatment with albuterol with or without an oral steroid.\n\nUsual care (albuterol with or without oral steroid): Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "8.7"}, {"groupId": "OG001", "value": "4.0"}]}]}]}, {"type": "SECONDARY", "title": "Urinary Cortisol Levels", "description": "This was defined as the mean +/- standard deviation of 12 hour urinary cortisol levels in each group (treatment with budesonide versus usual care).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ng cortisol/mg creatinine", "timeFrame": "3 weeks", "groups": [{"id": "OG000", "title": "Treatment With Budesonide", "description": "Subject is treated with nebulized budesonide 0.5 BID for 3 weeks\n\nNebulized Budesonide: Subject is treated with nebulized budesonide 0.5 BID for 3 weeks"}, {"id": "OG001", "title": "Usual Care", "description": "Subject is treated with usual care as provided by the doctor. Usual care normally consists of treatment with albuterol with or without an oral steroid.\n\nUsual care (albuterol with or without oral steroid): Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "95.4", "spread": "35.3"}, {"groupId": "OG001", "value": "141.6", "spread": "42.7"}]}]}]}, {"type": "SECONDARY", "title": "Forced Expiratory Volume in 1 Second (FEV1)", "description": "This was defined as the mean +/- standard deviation of FEV1 in each group (treatment with budesonide versus usual care.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "% Predicted", "timeFrame": "3 weeks", "groups": [{"id": "OG000", "title": "Treatment With Budesonide", "description": "Subject is treated with nebulized budesonide 0.5 BID for 3 weeks\n\nNebulized Budesonide: Subject is treated with nebulized budesonide 0.5 BID for 3 weeks"}, {"id": "OG001", "title": "Usual Care", "description": "Subject is treated with usual care as provided by the doctor. Usual care normally consists of treatment with albuterol with or without an oral steroid.\n\nUsual care (albuterol with or without oral steroid): Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "86.2", "spread": "2.5"}, {"groupId": "OG001", "value": "85.7", "spread": "3.1"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Treatment With Budesonide", "description": "Subject is treated with nebulized budesonide 0.5 BID for 3 weeks\n\nNebulized Budesonide: Subject is treated with nebulized budesonide 0.5 BID for 3 weeks", "seriousNumAffected": 0, "seriousNumAtRisk": 31, "otherNumAffected": 0, "otherNumAtRisk": 31}, {"id": "EG001", "title": "Usual Care", "description": "Subject is treated with usual care as provided by the doctor. Usual care normally consists of treatment with albuterol with or without an oral steroid.\n\nUsual care (albuterol with or without oral steroid): Subject is treated with usual care as prescribed by the doctor (normally albuterol with or without oral steroid)", "seriousNumAffected": 0, "seriousNumAtRisk": 30, "otherNumAffected": 0, "otherNumAtRisk": 30}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "David Skoner, MD", "organization": "Allegheny Singer Research Institute, WPAHS", "email": "dskoner@hsc.wvu.edu", "phone": "412-359-4099"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000012135", "term": "Respiratory Sounds"}], "ancestors": [{"id": "D000012818", "term": "Signs and Symptoms, Respiratory"}], "browseLeaves": [{"id": "M7796", "name": "Emergencies", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "relevance": "LOW"}, {"id": "M14972", "name": "Respiratory Sounds", "asFound": "Wheezing", "relevance": "HIGH"}, {"id": "M15623", "name": "Signs and Symptoms, Respiratory", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000019819", "term": "Budesonide"}, {"id": "D000000420", "term": "Albuterol"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000015149", "term": "Tocolytic Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M21711", "name": "Budesonide", "asFound": "Of 1", "relevance": "HIGH"}, {"id": "M3767", "name": "Albuterol", "asFound": "Diameter", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M17869", "name": "Tocolytic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Repr", "name": "Reproductive Control Agents"}]}}, "hasResults": true}